![]() 次世代シーケンサー(NGS)サービス-世界市場シェアとランキング、全体売上高と需要予測 2025-2031Next-Generation Sequencing (NGS) Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 次世代シーケンシング(NGS)サービスの世界市場規模は、2024年に4億9,400万米ドルと推定され、2031年には1億3,190万米ドルに再調整され、予測期間2025-2031年のCAGRは15.4%と予測されています。 次世代シーケン... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー次世代シーケンシング(NGS)サービスの世界市場規模は、2024年に4億9,400万米ドルと推定され、2031年には1億3,190万米ドルに再調整され、予測期間2025-2031年のCAGRは15.4%と予測されています。次世代シーケンシング(NGS)は、DNAまたはRNAサンプルの塩基対のシーケンスを迅速に行うハイスループット手法である。 次世代シーケンス(NGS)サービスの分類には、ターゲットシーケンス、ホールエクソームシーケンス、ホールゲノムシーケンスがあり、2019年のターゲットシーケンスの割合は約55%である。 次世代シーケンシング(NGS)サービスは、病院・クリニック、バイオ医薬品企業、学術・研究機関、その他で広く利用されている。次世代シーケンシング(NGS)サービスの最も大きな割合を占めるのは病院と診療所であり、2019年の割合は約56%である。 北米は最大の消費地であり、2019年の消費市場シェアは約37%である。北米に次いで欧州が2番目に大きな消費地で、消費市場シェアは約32%である。 Eurofins Scientific、Natera、BGI、Illuminaなどが業界のリーダーである。 本レポートは、次世代シーケンス(NGS)サービスの世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の次世代シーケンス(NGS)サービスの分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 次世代シークエンシング(NGS)サービスの市場規模、推計、予測は、2024年を基準年とし、2020年から2031年までの期間の履歴データと予測データを売上高(百万ドル)で提供しています。定量的および定性的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、次世代シーケンス(NGS)サービスに関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 ユーロフィンズサイエンティフィック Natera BGI イルミナ ロシュ ラボコープ ベリージェノミクス ブルックスライフサイエンス マクロジェン ペルソナリス ノボジェン ジェノタイピック・テクノロジー DNAリンク タイプ別セグメント ターゲットシーケンス 全エクソームシーケンス 全ゲノムシーケンス アプリケーション別 病院およびクリニック バイオ医薬品企業 学術・研究機関 その他 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章: レポートのスコープ、世界の総市場規模を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章 次世代シーケンサー(NGS)サービス企業の競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章:様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展の可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章:地域レベルでの次世代シーケンス(NGS)サービスの収益。各地域の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、市場規模を紹介しています。 第6章 次世代シーケンス(NGS)サービスの国別収益各国/地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章:主要企業のプロフィールを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本状況を詳細に紹介。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Next-Generation Sequencing (NGS) Services Product Introduction 1.2 Global Next-Generation Sequencing (NGS) Services Market Size Forecast (2020-2031) 1.3 Next-Generation Sequencing (NGS) Services Market Trends & Drivers 1.3.1 Next-Generation Sequencing (NGS) Services Industry Trends 1.3.2 Next-Generation Sequencing (NGS) Services Market Drivers & Opportunity 1.3.3 Next-Generation Sequencing (NGS) Services Market Challenges 1.3.4 Next-Generation Sequencing (NGS) Services Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Next-Generation Sequencing (NGS) Services Players Revenue Ranking (2024) 2.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025) 2.3 Key Companies Next-Generation Sequencing (NGS) Services Manufacturing Base Distribution and Headquarters 2.4 Key Companies Next-Generation Sequencing (NGS) Services Product Offered 2.5 Key Companies Time to Begin Mass Production of Next-Generation Sequencing (NGS) Services 2.6 Next-Generation Sequencing (NGS) Services Market Competitive Analysis 2.6.1 Next-Generation Sequencing (NGS) Services Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Next-Generation Sequencing (NGS) Services Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing (NGS) Services as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Targeted Sequencing 3.1.2 Whole Exome Sequencing 3.1.3 Whole Genome Sequencing 3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type 3.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (2020-2031) 3.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals and Clinics 4.1.2 Biopharma Companies 4.1.3 Academic & Research Organizations 4.1.4 Others 4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application 4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (2020-2031) 4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region 5.1.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025) 5.1.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031) 5.1.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.2.2 North America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.3.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.4.2 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.5.2 South America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.6.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.3 United States 6.3.1 United States Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.3.2 United States Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.4.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.5.2 China Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.5.3 China Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.6.2 Japan Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.7.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.8.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.9.2 India Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.9.3 India Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Eurofins Scientific 7.1.1 Eurofins Scientific Profile 7.1.2 Eurofins Scientific Main Business 7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.1.5 Eurofins Scientific Recent Developments 7.2 Natera 7.2.1 Natera Profile 7.2.2 Natera Main Business 7.2.3 Natera Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.2.5 Natera Recent Developments 7.3 BGI 7.3.1 BGI Profile 7.3.2 BGI Main Business 7.3.3 BGI Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.3.5 BGI Recent Developments 7.4 Illumina 7.4.1 Illumina Profile 7.4.2 Illumina Main Business 7.4.3 Illumina Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.4.5 Illumina Recent Developments 7.5 Roche 7.5.1 Roche Profile 7.5.2 Roche Main Business 7.5.3 Roche Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.5.5 Roche Recent Developments 7.6 LabCorp 7.6.1 LabCorp Profile 7.6.2 LabCorp Main Business 7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.6.5 LabCorp Recent Developments 7.7 Berry Genomics 7.7.1 Berry Genomics Profile 7.7.2 Berry Genomics Main Business 7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.7.5 Berry Genomics Recent Developments 7.8 Brooks Life Sciences 7.8.1 Brooks Life Sciences Profile 7.8.2 Brooks Life Sciences Main Business 7.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.8.5 Brooks Life Sciences Recent Developments 7.9 Macrogen 7.9.1 Macrogen Profile 7.9.2 Macrogen Main Business 7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.9.5 Macrogen Recent Developments 7.10 Personalis 7.10.1 Personalis Profile 7.10.2 Personalis Main Business 7.10.3 Personalis Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.10.4 Personalis Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.10.5 Personalis Recent Developments 7.11 Novogene 7.11.1 Novogene Profile 7.11.2 Novogene Main Business 7.11.3 Novogene Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.11.5 Novogene Recent Developments 7.12 Genotypic Technology 7.12.1 Genotypic Technology Profile 7.12.2 Genotypic Technology Main Business 7.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.12.5 Genotypic Technology Recent Developments 7.13 Dna Link 7.13.1 Dna Link Profile 7.13.2 Dna Link Main Business 7.13.3 Dna Link Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.13.4 Dna Link Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.13.5 Dna Link Recent Developments 8 Industry Chain Analysis 8.1 Next-Generation Sequencing (NGS) Services Industrial Chain 8.2 Next-Generation Sequencing (NGS) Services Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Next-Generation Sequencing (NGS) Services Sales Model 8.5.2 Sales Channel 8.5.3 Next-Generation Sequencing (NGS) Services Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Next-Generation Sequencing (NGS) Services was estimated to be worth US$ 4904 million in 2024 and is forecast to a readjusted size of US$ 13190 million by 2031 with a CAGR of 15.4% during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Next-Generation Sequencing (NGS) Services Product Introduction 1.2 Global Next-Generation Sequencing (NGS) Services Market Size Forecast (2020-2031) 1.3 Next-Generation Sequencing (NGS) Services Market Trends & Drivers 1.3.1 Next-Generation Sequencing (NGS) Services Industry Trends 1.3.2 Next-Generation Sequencing (NGS) Services Market Drivers & Opportunity 1.3.3 Next-Generation Sequencing (NGS) Services Market Challenges 1.3.4 Next-Generation Sequencing (NGS) Services Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Next-Generation Sequencing (NGS) Services Players Revenue Ranking (2024) 2.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025) 2.3 Key Companies Next-Generation Sequencing (NGS) Services Manufacturing Base Distribution and Headquarters 2.4 Key Companies Next-Generation Sequencing (NGS) Services Product Offered 2.5 Key Companies Time to Begin Mass Production of Next-Generation Sequencing (NGS) Services 2.6 Next-Generation Sequencing (NGS) Services Market Competitive Analysis 2.6.1 Next-Generation Sequencing (NGS) Services Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Next-Generation Sequencing (NGS) Services Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing (NGS) Services as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Targeted Sequencing 3.1.2 Whole Exome Sequencing 3.1.3 Whole Genome Sequencing 3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type 3.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (2020-2031) 3.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals and Clinics 4.1.2 Biopharma Companies 4.1.3 Academic & Research Organizations 4.1.4 Others 4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application 4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (2020-2031) 4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region 5.1.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025) 5.1.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031) 5.1.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.2.2 North America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.3.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.4.2 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.5.2 South America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 5.6.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.3 United States 6.3.1 United States Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.3.2 United States Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.4.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.5.2 China Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.5.3 China Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.6.2 Japan Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.7.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.8.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031 6.9.2 India Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031 6.9.3 India Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Eurofins Scientific 7.1.1 Eurofins Scientific Profile 7.1.2 Eurofins Scientific Main Business 7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.1.5 Eurofins Scientific Recent Developments 7.2 Natera 7.2.1 Natera Profile 7.2.2 Natera Main Business 7.2.3 Natera Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.2.5 Natera Recent Developments 7.3 BGI 7.3.1 BGI Profile 7.3.2 BGI Main Business 7.3.3 BGI Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.3.5 BGI Recent Developments 7.4 Illumina 7.4.1 Illumina Profile 7.4.2 Illumina Main Business 7.4.3 Illumina Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.4.5 Illumina Recent Developments 7.5 Roche 7.5.1 Roche Profile 7.5.2 Roche Main Business 7.5.3 Roche Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.5.5 Roche Recent Developments 7.6 LabCorp 7.6.1 LabCorp Profile 7.6.2 LabCorp Main Business 7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.6.5 LabCorp Recent Developments 7.7 Berry Genomics 7.7.1 Berry Genomics Profile 7.7.2 Berry Genomics Main Business 7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.7.5 Berry Genomics Recent Developments 7.8 Brooks Life Sciences 7.8.1 Brooks Life Sciences Profile 7.8.2 Brooks Life Sciences Main Business 7.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.8.5 Brooks Life Sciences Recent Developments 7.9 Macrogen 7.9.1 Macrogen Profile 7.9.2 Macrogen Main Business 7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.9.5 Macrogen Recent Developments 7.10 Personalis 7.10.1 Personalis Profile 7.10.2 Personalis Main Business 7.10.3 Personalis Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.10.4 Personalis Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.10.5 Personalis Recent Developments 7.11 Novogene 7.11.1 Novogene Profile 7.11.2 Novogene Main Business 7.11.3 Novogene Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.11.5 Novogene Recent Developments 7.12 Genotypic Technology 7.12.1 Genotypic Technology Profile 7.12.2 Genotypic Technology Main Business 7.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.12.5 Genotypic Technology Recent Developments 7.13 Dna Link 7.13.1 Dna Link Profile 7.13.2 Dna Link Main Business 7.13.3 Dna Link Next-Generation Sequencing (NGS) Services Products, Services and Solutions 7.13.4 Dna Link Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025) 7.13.5 Dna Link Recent Developments 8 Industry Chain Analysis 8.1 Next-Generation Sequencing (NGS) Services Industrial Chain 8.2 Next-Generation Sequencing (NGS) Services Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Next-Generation Sequencing (NGS) Services Sales Model 8.5.2 Sales Channel 8.5.3 Next-Generation Sequencing (NGS) Services Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(demand)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|